Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for sedation during orthopedic surgery under ultrasound-guided nerve block
ChiCTR2200065844Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and dexmedetomidine (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Patient satisfaction, Bispectral index value and 1 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
remimazolamdexmedetomidine
Beyond the preview
Go deeper on ChiCTR2200065844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065844.